Israeli - Kiingereza - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 2 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episod

Israeli - Kiingereza - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 3 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episod

Israeli - Kiingereza - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 4 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episod

Israeli - Kiingereza - Ministry of Health

unipharm ltd, israel - risperidone - solution - risperidone 1 mg/ml - risperidone - risperidone - rispond is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of rispond was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. rispond is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. rispond is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. rispond is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

Israeli - Kiingereza - Ministry of Health

vitamed pharmaceutical industries ltd - doxycycline as hyclate - capsules - doxycycline as hyclate 100 mg - doxycycline - doxycycline - treatment of infections due to bacteria which are sensitive to the product. for the prevention of malaria when orher drugs are not suitable or when the malaria parasite is resistant to other drugs, especially to mefloquine.

Israeli - Kiingereza - Ministry of Health

vitamed pharmaceutical industries ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 50 mg - minocycline - minocycline - antibiotic indicated against infections caused by bacteria sensitive to minocycline, and for the treatment of acne.

Israeli - Kiingereza - Ministry of Health

rekah pharmaceutical industry ltd, israel - levomepromazine as maleate - tablets - levomepromazine as maleate 100 mg - levomepromazine - treatment of psychotic disorders, particulary to produce a tranquillizing effect on hyperactive or excited psychotic patients and in patients suffering from anxiety, tension and behavioural disorders.

Israeli - Kiingereza - Ministry of Health

rekah pharmaceutical industry ltd, israel - levomepromazine as maleate - tablets - levomepromazine as maleate 25 mg - phenothiazine with aliphatic side-chain - treatment of psychotic disorders, particulary to produce a tranquillizing effect on hyperactive or excited psychotic patients and in patients suffering from anxiety, tension and behavioural disorders.

Israeli - Kiingereza - Ministry of Health

padagis israel agencies ltd, israel - digoxin - elixir - digoxin 0.05 mg / 1 ml - digoxin - digoxin - lanoxin is indicated whenever digitalis therapy is required for the treatment of congestive heart failure, atrial fibrilation and/or flutter and supra-ventricular tachycardia.

Israeli - Kiingereza - Ministry of Health

trima israel pharmaceutical products maabarot ltd - clobetasol propionate - solution - external - clobetasol propionate 0.05 %w/w - clobetasol - for the topical treatment of inflammatory conditions of the scalp responsive only to corticosteroids.